GlassScriptPhysician profile
David A Mackoul
NPI 1871582056
$299.00
in general payments reported to CMS, 2019-2025
10 companies · $122 in 2025
The $122 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.80 · 2021: $39.72 · 2022: $15.65 · 2023: $57.63 · 2024: $19.71 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $55.70 | 2019-2025 | |
| Exeltis, USA INC. | $43.26 | 2024-2025 | Slynd |
| Merck Sharp & Dohme LLC | $42.78 | 2021-2023 | Vaxneuvance, Varivax, M-M-R II |
| Phadia US INC. | $38.65 | 2025 | Immunocap |
| Ipsen Biopharmaceuticals, INC | $26.26 | 2023 | Sohonos |
| Glaxosmithkline, LLC. | $24.87 | 2019-2021 | |
| Seqirus USA INC | $21.94 | 2025 | Flucelvax |
| Collegium Pharmaceutical, INC. | $16.96 | 2025 | Jornay Pm |
| Tris Pharma INC | $16.64 | 2021 | |
| Shire North American Group INC | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mackoul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.